ARVIS® Shoulder
Kico Knee Innovation Company Pty Ltd • Neurology • 01/13/2025
Device Purpose
The ARVIS® Shoulder is a Class II computer-controlled stereotaxic navigation system designed to enhance surgical precision in total shoulder arthroplasty. It achieves this by providing augmented reality visualization and enabling accurate intraoperative measurements and implant positioning based on preoperative imaging data.
Summary
Kico Knee Innovation Company Pty Ltd's ARVIS® Shoulder device has received regulatory clearance, being determined substantially equivalent to legally marketed devices. Classified as a Class II stereotaxic instrument, its primary indication is to assist surgeons in the precise positioning and alignment of implants during stereotactic orthopedic surgery, specifically for total shoulder arthroplasty. This system is designed to enhance accuracy relative to reference axes and anatomical landmarks. The ARVIS® Shoulder functions as a computer-controlled navigation system, providing surgeons with capabilities for intraoperative measurements and localization of anatomical structures based on the patient's preoperative imaging. It incorporates an innovative head-mounted ARVIS® Eyepiece for augmented reality visualization and real-time information display. The device's core technological principles, main system components, and navigation tracking technology are consistent with previously reviewed devices, and its compatibility has been broadened to support additional implant systems. Marketing is permitted contingent on adherence to ongoing regulatory standards.
AI Regulatory Concerns
Powered by
Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.
Keywords
Device Metadata
Relevant Clinical Questions
- Q1. What specific clinical data or studies support the claim of substantial equivalence and demonstrate improved surgical outcomes or reduced complications with the ARVIS® Shoulder system?; How does the integration of the head-mounted ARVIS® Eyepiece for augmented reality visualization compare in terms of accuracy and surgeon workflow to other existing navigation systems for shoulder arthroplasty?; What are the system's limitations regarding patient anatomy, surgical complexity, or operating room environment that might affect its performance or applicability?; What is the required training and learning curve for surgeons to effectively utilize the ARVIS® Shoulder system, particularly concerning its augmented reality features?; How does the expanded compatibility with additional implant systems impact the device's versatility and adoption across different surgical practices and what validation was performed for these new compatibilities?
Risk Classification
ESL AnalysisFDA Class II via 510(k) pathway; IEC 62304 Class B (software safety classification); Post-§524B but no clear network capability detected
Learn how Parasoft automates IEC 62304 compliance testing →Cybersecurity Evidence
Powered by SBOMator™Based on AI-generated device summaries, not the full FDA submission. Items not detected here may still be present in the complete submission package.
Supply Chain BOM Evidence
Based on the CycloneDX / OWASP ECMA-424 xBOM ecosystem. Detection is from the AI-generated summary.
Analysis:
• Analysis is based on the AI-generated device summary, not the full FDA submission package. Click "Analyze Full FDA PDF" below to scan the actual submission document.
• Evidence of OBOM detected in AI-generated device summary.
• SBOM not mentioned in AI-generated device summary. Under §524B (effective Oct 2023), cyber devices must provide a SBOM.
• Cybersecurity risk assessment not referenced in AI-generated device summary. FDA cybersecurity guidance (2023) expects this for cyber devices.
• Postmarket cybersecurity monitoring plan not clearly documented in AI-generated device summary.
• Not detected in AI-generated device summary: SBOM, ML-BOM, SaaSBOM, HBOM, CBOM, VDR/VEX. These may be present in the full FDA submission.
Preparing a similar submission?
ESL takes complete ownership of your software evidence work - SBOM & CVE remediation with SBOMator™, static analysis & unit testing with Parasoft, traceability, and full IEC 62304 lifecycle support.
Assess Your Readiness →Or contact ESL directly